Showing results (51-60 of 9,398) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|September 8, 2015
Heritability of metoprolol and torsemide pharmacokineticsJ Matthaei, J Brockmöller, M V Tzvetkov, et al.
Clinical Pharmacology and Therapeutics|September 10, 2015
Medical decision support systems and therapeutics: The role of autopilotsR L Woosley, J Whyte, A Mohamadi, et al.
Clinical Pharmacology and Therapeutics|September 1, 1989
Nicotine enhances the circulatory effects of adenosine in human beingsP Smits, A Eijsbouts, T Thien
Clinical Pharmacology and Therapeutics|September 1, 1989
Differential effects of viqualine on alcohol intake and other consummatory behaviorsC A Naranjo, J T Sullivan, K E Kadlec, et al.
Clinical Pharmacology and Therapeutics|January 23, 2016
Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5K Yoshida, B Sun, L Zhang, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
The natural history of medication compliance in a drug trial: limitations of pill countsP Rudd, R L Byyny, V Zachary, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicinS P Ackland, M J Ratain, N J Vogelzang, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Racial differences in drug response: isoproterenol effects on heart rate following intravenous metoprololD R Rutledge, J Steinberg, L Cardozo
Clinical Pharmacology and Therapeutics|April 1, 1989
Acute effects of lidocaine on repolarization and conduction in patients with coronary artery diseaseK Endresen, J P Amlie
Clinical Pharmacology and Therapeutics|April 1, 1989
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemiaJ P Dutcher, C E Riggs, J J Strauman, et al.
Pageof 940